Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318143 | SCV000851330 | uncertain significance | Inborn genetic diseases | 2018-05-14 | criteria provided, single submitter | clinical testing | The p.H390P variant (also known as c.1169A>C), located in coding exon 12 of the ATP13A2 gene, results from an A to C substitution at nucleotide position 1169. The histidine at codon 390 is replaced by proline, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002485813 | SCV002784089 | uncertain significance | Kufor-Rakeb syndrome; Autosomal recessive spastic paraplegia type 78 | 2021-08-17 | criteria provided, single submitter | clinical testing |